EPA:BLC - FR0000035370 - Common Stock
The current stock price of BLC.PA is 24 EUR. In the past month the price decreased by -16.81%. In the past year, price increased by 12.15%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
AMP.MI | AMPLIFON SPA | 26.34 | 3.46B | ||
FAGR.BR | FAGRON | 17.84 | 1.54B | ||
UPR.I | UNIPHAR PLC | 15.76 | 1.02B | ||
ILM1.DE | MEDIOS AG | 24.68 | 371.43M | ||
VMED.DE | VIROMED MEDICAL AG | N/A | 67.23M | ||
PRE.MI | PREDICT SPA | 14.58 | 4.87M |
Bastide Le Confort Médical SA is engaged in the provision and rental of medical supplies and equipment for elderly, sick and handicapped people, and healthcare professionals. The company is headquartered in Caissargues, Occitanie and currently employs 3,651 full-time employees. The firm activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The firm provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. The company offers devices to support diabetic patients towards daily comfort and a normal life. The firm offers wide range of products and services to relieve patients losing their autonomy. The company fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.
BASTIDE LE CONFORT MEDICAL
Centre d'activite Euro 2000, 12 avenue de la Dame
Caissargues OCCITANIE FR
Employees: 3635
Phone: 33466386808
The current stock price of BLC.PA is 24 EUR. The price decreased by -5.88% in the last trading session.
The exchange symbol of BASTIDE LE CONFORT MEDICAL is BLC and it is listed on the Euronext Paris - Matif exchange.
BLC.PA stock is listed on the Euronext Paris - Matif exchange.
6 analysts have analysed BLC.PA and the average price target is 36.72 EUR. This implies a price increase of 53% is expected in the next year compared to the current price of 24. Check the BASTIDE LE CONFORT MEDICAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a market capitalization of 176.88M EUR. This makes BLC.PA a Micro Cap stock.
BASTIDE LE CONFORT MEDICAL (BLC.PA) currently has 3635 employees.
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a support level at 23.99 and a resistance level at 27.49. Check the full technical report for a detailed analysis of BLC.PA support and resistance levels.
The Revenue of BASTIDE LE CONFORT MEDICAL (BLC.PA) is expected to grow by 5.64% in the next year. Check the estimates tab for more information on the BLC.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BLC.PA does not pay a dividend.
BASTIDE LE CONFORT MEDICAL (BLC.PA) will report earnings on 2025-10-22, after the market close.
The PE ratio for BASTIDE LE CONFORT MEDICAL (BLC.PA) is 109.09. This is based on the reported non-GAAP earnings per share of 0.22 and the current share price of 24 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BLC.PA.
ChartMill assigns a fundamental rating of 4 / 10 to BLC.PA. BLC.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months BLC.PA reported a non-GAAP Earnings per Share(EPS) of 0.22. The EPS decreased by -71.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.32% | ||
ROA | 0.25% | ||
ROE | 2.25% | ||
Debt/Equity | 5.2 |
6 analysts have analysed BLC.PA and the average price target is 36.72 EUR. This implies a price increase of 53% is expected in the next year compared to the current price of 24.
For the next year, analysts expect an EPS growth of -4.84% and a revenue growth 5.64% for BLC.PA